Correlation Between Amgen and CSPC Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Amgen and CSPC Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amgen and CSPC Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amgen Inc and CSPC Pharmaceutical Group, you can compare the effects of market volatilities on Amgen and CSPC Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amgen with a short position of CSPC Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amgen and CSPC Pharmaceutical.

Diversification Opportunities for Amgen and CSPC Pharmaceutical

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between Amgen and CSPC is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Amgen Inc and CSPC Pharmaceutical Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CSPC Pharmaceutical and Amgen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amgen Inc are associated (or correlated) with CSPC Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CSPC Pharmaceutical has no effect on the direction of Amgen i.e., Amgen and CSPC Pharmaceutical go up and down completely randomly.

Pair Corralation between Amgen and CSPC Pharmaceutical

Given the investment horizon of 90 days Amgen Inc is expected to under-perform the CSPC Pharmaceutical. But the stock apears to be less risky and, when comparing its historical volatility, Amgen Inc is 5.29 times less risky than CSPC Pharmaceutical. The stock trades about -0.17 of its potential returns per unit of risk. The CSPC Pharmaceutical Group is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  62.00  in CSPC Pharmaceutical Group on August 30, 2024 and sell it today you would earn a total of  5.00  from holding CSPC Pharmaceutical Group or generate 8.06% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Amgen Inc  vs.  CSPC Pharmaceutical Group

 Performance 
       Timeline  
Amgen Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Amgen Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
CSPC Pharmaceutical 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in CSPC Pharmaceutical Group are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, CSPC Pharmaceutical reported solid returns over the last few months and may actually be approaching a breakup point.

Amgen and CSPC Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Amgen and CSPC Pharmaceutical

The main advantage of trading using opposite Amgen and CSPC Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amgen position performs unexpectedly, CSPC Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CSPC Pharmaceutical will offset losses from the drop in CSPC Pharmaceutical's long position.
The idea behind Amgen Inc and CSPC Pharmaceutical Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk